Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002625)

(Analysis AN004297)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11
hypoxanthine	ME623073	0.07	0.20	6.53	0.08	0.08	0.21	0.09	0.08	0.15	0.07	0.13
AICAR	ME623058	0.42	0.54	1.11	0.38	0.35	3.92	1.08	0.55	0.89	0.51	0.81
NaMN	ME623080	0.85	0.63	0.81	0.89	0.34	3.78	1.54	0.95	1.01	0.48	0.38
S-adenosylhomocysteine	ME623083	0.26	0.56	3.46	0.45	0.50	1.01	0.74	0.47	0.70	0.30	1.09
guanosine	ME623071	0.49	0.66	2.65	0.70	0.45	0.99	0.88	0.54	0.73	0.62	1.29
IMP	ME623074	0.65	1.38	2.66	0.55	0.48	0.61	1.15	0.33	0.63	0.43	1.13
NADH	ME623077	0.04	1.44	0.21	0.15	0.18	0.46	3.06	NA	0.14	0.62	3.34
NADPH	ME623079	0.07	1.89	0.07	0.02	0.48	0.27	2.97	NA	0.12	0.76	3.17
ZMP	ME623090	0.94	0.54	0.51	1.05	0.12	1.77	1.38	2.31	0.27	1.37	1.22
AMP	ME623059	0.21	2.17	0.66	0.25	0.67	0.37	1.50	0.51	0.86	0.39	3.63
UMP	ME623087	0.30	2.23	0.76	0.30	0.57	0.39	1.35	0.60	0.85	0.49	3.32
ADP-ribose	ME623057	0.48	1.85	1.38	0.69	0.59	0.68	0.96	0.92	0.78	0.87	1.58
S-AMP	ME623084	0.12	1.48	1.89	0.35	0.65	0.99	1.40	0.25	0.80	0.35	2.19
CMP	ME623062	0.33	1.79	1.34	0.23	0.84	0.37	1.50	0.55	0.91	0.61	2.29
GMP	ME623069	0.24	1.78	1.74	0.29	0.50	0.37	1.37	0.37	0.79	0.38	2.72
PRPP	ME623082	1.02	1.28	0.41	0.61	0.46	1.31	1.74	0.52	0.44	1.22	2.35
GDP-mannose	ME623068	0.91	1.44	0.33	1.10	0.56	0.64	2.09	0.55	1.08	1.42	1.28
ATP	ME623060	0.95	1.27	0.10	1.32	1.08	0.78	2.00	0.52	1.10	1.36	1.06
GTP	ME623070	0.90	1.45	0.04	0.98	0.89	0.83	2.07	0.55	1.12	1.53	1.21
CTP	ME623063	0.84	1.39	0.01	0.98	0.96	0.85	2.33	0.48	1.20	1.61	0.95
UTP	ME623088	0.83	1.40	0.01	0.99	0.89	0.78	2.47	0.46	1.21	1.49	1.06
NAD+	ME623076	0.69	1.45	0.08	0.90	0.97	0.60	2.31	0.47	1.21	1.03	1.82
UDP-galactose	ME623086	0.77	1.38	0.36	0.92	0.63	0.56	2.61	0.43	1.33	1.11	1.28
ADP	ME623056	0.49	1.85	0.17	0.69	0.93	0.54	1.83	0.45	1.02	0.83	2.68
GDP	ME623067	0.56	1.85	0.48	0.59	0.75	0.57	1.79	0.57	0.99	1.01	2.14
NADP+	ME623078	0.36	2.08	0.49	0.42	1.24	0.36	2.19	0.35	1.26	0.52	2.05
CDP	ME623061	0.43	2.21	0.08	0.41	0.97	0.56	2.15	0.62	1.23	1.00	1.89
UDP	ME623085	0.38	1.92	0.03	0.43	0.86	0.40	2.44	0.47	1.30	0.99	2.36
dTTP	ME623066	0.68	0.68	0.50	0.89	0.62	2.35	1.98	1.02	1.05	0.88	0.63
dATP	ME623064	0.71	0.81	0.61	0.91	0.66	1.71	2.33	0.69	1.07	1.03	0.70
dCTP	ME623065	0.59	1.26	0.29	0.80	0.75	1.62	2.25	0.74	1.09	1.19	0.84
guanine	ME623072	0.42	1.06	1.09	0.81	0.70	1.81	1.75	0.73	0.90	0.77	0.90
XMP	ME623089	0.67	1.12	0.88	1.20	0.09	1.91	1.66	0.43	1.15	0.85	0.51
5^-methylthioadenosine	ME623075	0.38	0.73	1.30	0.51	0.80	1.44	1.56	0.46	0.98	0.61	1.86
adenine	ME623055	0.98	0.98	1.01	0.98	0.93	0.97	0.96	1.16	0.99	0.93	1.12
NMN	ME623081	0.64	0.62	1.98	0.65	0.56	1.01	1.14	1.11	0.72	0.73	1.17

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-ExternalStandard \| Timepoint:0 hour \| Sex:-
F4	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F5	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F6	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F7	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F8	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F9	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F10	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F11	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix